Canadians are rightfully pleased that our country is now among the world leaders in COVID-19 vaccination rates. At the same time, however, our excitement is tempered by the recognition that we have been so dependent on foreign producers to make it happen. Among the many eye-opening impacts of the global pandemic, Canada’s inability to develop and produce vaccines domestically has…
Read More
On May 25, 2021, Member of Parliament Kirsty Duncan advanced Motion 38 to create a new Standing Committee for Science and Research (SCSR). The motion received unanimous support from all parties with a vote of 331-0. It recognizes that science and research are of critical importance and essential ingredients to informed decision-making across the economic, environmental and social challenges in Canada.…
Read More
Colleges are at the forefront of applied research and development, and their work is vital to driving innovation and delivering tangible benefits within their regions. Since the beginning of the COVID-19 pandemic, they have shown great strength and resiliency by rapidly mobilizing their resources to conduct pandemic-related applied research, while also maintaining R&D support for local small- to medium-sized enterprises…
Read More
A pair of Canadian biotechnology venture capital firms have launched new programs to arm academics with entrepreneurial skills in an effort to help fix a chronic talent gap in the country’s burgeoning life sciences sector. The programs, by Lumira Ventures and Amplitude Venture Capital, join a growing mass of Canadian initiatives aiming to expand the shallow pool of domestic executives…
Read More
The federal budget highlighted the vital role biotechnology innovation is playing in addressing the COVID-19 pandemic while aiming to prepare for future pandemic needs and serves as one of the identified key sectors set to drive the economic recovery for Canada. Biotechnology featured as a priority area for the government across many program announcements, reflecting specific industry recommendations including improving…
Read More
Dr. Lakshmi Krishnan explains how increased investment will greatly benefit Canada’s prospects for a future bioeconomy, allowing for the development of more early-stage innovations but more importantly, giving those companies a pathway to scaling up. A thriving bioeconomy will help Canada tackle key health issues from cancer to future pandemics.
Read More
Bioengineering and biomanufacturing are new ways of making products that we need and use every day, but they are built on old principles. I would like to illustrate how biomanufacturing works by using a couple of examples, and I am going to use medicines and soap because those are two things we really need during this pandemic. When we think about…
Read More
Former LSI Director Dr. Pieter Cullis and University of Toronto’s Shana Kelly published today an Op-Ed in the Hill Times calling for growing the biotech industry to accelerate growth of  knowledge-based economy, and to promote economic prosperity. “The COVID- 19 pandemic has exposed the fact that Canada lacks biopharmaceutical and vaccine manufacturing capacity,” write the co-authors. “At the same time,…
Read More
The Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC), and the Social Sciences and Humanities Research Council (SSHRC) are pleased to launch a special $2.25 million funding opportunity to support activities that promote vaccine confidence in Canada. The agencies expect these activities will improve public understanding of vaccines and help Canadians to make evidence-based decisions, especially…
Read More